Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring.

Molecular & cellular proteomics : MCP - 1 Oct 2013

Végvári Akos, Sjödin Karin, Rezeli Melinda, Malm Johan, Lilja Hans, Laurell Thomas, Marko-Varga György

Abstract excerpt

Prostate specific antigen (PSA) is a well-established tumor marker that is frequently employed as model biomarker in the development and evaluation of emerging quantitative proteomics techniques, partially as a result of wide access to commercialized immunoassays serving as "gold standards." We d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Assay
Share to Biomarkers, Tumor
Share to Oligopeptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Plasma

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Protein Isoforms

Source

Open in PubMed Open full text

Identifiers

PMID: 23842001
DOI: 10.1074/mcp.M113.028365
PMCID: PMC3790289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23842001-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring.PMID 23842001Read ↗

Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.Semantic proximity Read ↗

Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination.Semantic proximity Read ↗

Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.Semantic proximity Read ↗

Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detectionSemantic proximity Read ↗

Characterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC-MS/MS.Semantic proximity Read ↗

Kallikreins as Biomarkers for Prostate CancerSemantic proximity Read ↗

Mass spectrometry-based targeted proteomics for analysis of protein mutations.Semantic proximity Read ↗

The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.Semantic proximity Read ↗

Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation.Semantic proximity Read ↗

A Multiplexed Quantitative Analysis of Germline Single Amino Acid Variants by Targeted Proteomics in Nondepleted Human Plasma.Semantic proximity Read ↗

Unusual Alternative Splicing within the Human Kallikrein Genes KLK2 and KLK3 Gives Rise to Novel Prostate-specific ProteinsSemantic proximity Read ↗

Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.